This proposal was proposed in a previous session of Congress.

You can no longer write a comment about this proposal.

View Funding Neurofibromatosis Research report

What’s your position on
Funding Neurofibromatosis Research

Continued FY 2013 Funding of the Congressionally Directed Medical Research Program (CDMRP) in Neurofibromatosis Research

Neurofibromatosis (NF) occurs in one in every 3,000 births (more than cystic fibrosis, Duchenne muscular dystrophy, and Huntington’s disease combined). It causes tumors to grow along the nervous system and can lead to blindness, bone abnormalities, cancer, deafness, disfigurement, learning disabilities, and excruciating and disabling pain. Research conducted within the Department of Defense Congressionally Directed Medical Research Program (CDMRP) has made great strides, but is at a critical stage. Continued funding is needed to translate clinical trials into effective treatments. (Proposed by the Children's Tumor Foundation.)

This proposal was proposed in a previous session of Congress. You can no longer write a comment about this proposal.

What POPVOX Users Say

POPVOX Nation:
92% Support
8% Oppose
(1,227 users)

View Report & Comments

1124 users
103 users
order determined by social media popularity

Endorsing Organizations

Children's Tumor Foundation (CTF) 13,027 Facebook fans 2,798 Twitter followers

Neurofibromatosis (NF) occurs in one in every 3,000 births (more than cystic fibrosis, Duchenne muscular dystrophy, and Huntington’s disease combined). It causes tumors to grow along the nervous system and can lead to blindness, bone abnormalities, cancer, deafness, disfigurement, learning disabilities, and excruciating and disabling pain. NF research is at a critical stage – great strides have been made but continued funding is needed to translate clinical trials into effective treatments. With your support, we can move closer to the goal of successful therapies for NF, and improve the lives of those affected.

Read full position statement.